All posts by: Michael Zand

About Michael Zand

Mesoblast wins Japanese approval for stem cell product – The Australian Financial Review

Continue reading

2015-09-23 NEWS

The Australian Financial Review

Mesoblast wins Japanese approval for stem cell product
The Australian Financial Review
TEMCELL is indicated as a treatment for children/adults with acute Graft Versus Host Disease (aGvHD) a severe complication arising from a hemopoietic stem cell transplant—HSCT (a treatment for certain cancers which utilises stem cells derived from

Continue reading

2015-09-23 NEWS

Futurity: Research News

Stem cell ‘organoid’ mimics developing brain
Futurity: Research News
The researchers have developed a screening system for predicting developmental neurotoxicity—damage caused to nervous tissue by toxic substances—using stem cells to model features of the developing human brain. The findings appear in the …
A Barrier Against Brain Stem Cell AgingScience 2.0
Researchers Isolate Human Muscle Stem CellsUCSF News Services
The Market for Stem Cell Biobanking and Storage – Size, Segments, and TrendsPR Newswire (press release)

all 16 news articles »